Three execs join Dendreon's ranks
This article was originally published in Scrip
Executive Summary
Dendreon has appointed three new vice-presidents to its executive team: Joe dePinto, most recently vice-president for ImClone Systems, joins the team as executive vice-president of global commercial operations; Robert Poulton, currently Dendreon's global head of quality, has been appointed executive vice-president of technical operations; and Christine Mikhail, previously senior vice-president of corporate development at Savient Pharmaceuticals, joins as executive vice-president of corporate development, general counsel and secretary. All three will report to John Johnson, Dendreon's president and CEO.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.